🇺🇸 FDA
Patent

US 6203787

Treating tumors using implants comprising combinations of allogeneic cells

expired A61KA61K2039/5152A61K2239/31

Quick answer

US patent 6203787 (Treating tumors using implants comprising combinations of allogeneic cells) held by The Regents of the University of California expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/5152, A61K2239/31, A61K2239/38, A61K2239/48